Health IT victory

In what is being hailed as a victory for the Meaningful Use program and care quality efforts, the big news this week was the report that health IT is working when it comes to reducing medical errors. Hospitals committed 17 percent fewer medical errors in 2013 than in 2010, and this increase in patient safety saved the lives of 50,000 people, according to the Department of Health and Human Services (HHS).

A reduction of 1.3 million incidences of hospital-acquired conditions from 2010 to 2013 also saved approximately $12 billion, according to the HHS report. 

"This progress toward a safer health care system occurred during a period of concerted attention by hospitals throughout the country to reduce adverse events," according to the department's announcement. The efforts were due in part to provisions of the Affordable Care Act such as Medicare payment incentives to improve the quality of care and the HHS Partnership for Patients initiative.

“These data represent significant progress in improving the quality of care that patients receive while spending our health care dollars more wisely," said HHS Secretary Sylvia M. Burwell. "HHS will work with partners across the country to continue to build on this progress.”

“We have built an ‘infrastructure of improvement’ that will aid hospitals and the healthcare field for years to come," Rich Umbdenstock, president and CEO of the American Hospital Association.

Does this report help with the culture change at your organization? Are you experiencing the benefits of this infrastructure of improvement? Please share your thoughts.

Beth Walsh

Clinical Innovation + Technology editor

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.